Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder.

TitleSynaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder.
Publication TypeJournal Article
Year of Publication2017
AuthorsLipstein N, Verhoeven-Duif NM, Michelassi FE, Calloway N, van Hasselt PM, Pienkowska K, van Haaften G, van Haelst MM, van Empelen R, Cuppen I, van Teeseling HC, Evelein AMV, Vorstman JA, Thoms S, Jahn O, Duran KJ, Monroe GR, Ryan TA, Taschenberger H, Dittman JS, Rhee J-S, Visser G, Jans JJ, Brose N
JournalJ Clin Invest
Volume127
Issue3
Pagination1005-1018
Date Published2017 Mar 01
ISSN1558-8238
KeywordsAmino Acid Substitution, Animals, Caenorhabditis elegans, Caenorhabditis elegans Proteins, Cell Line, Female, Humans, Infant, Male, Motor Disorders, Mutation, Missense, Nerve Tissue Proteins, Neuronal Plasticity, Neurons, Synaptic Transmission, Synaptic Vesicles
Abstract

Munc13 proteins are essential regulators of neurotransmitter release at nerve cell synapses. They mediate the priming step that renders synaptic vesicles fusion-competent, and their genetic elimination causes a complete block of synaptic transmission. Here we have described a patient displaying a disorder characterized by a dyskinetic movement disorder, developmental delay, and autism. Using whole-exome sequencing, we have shown that this condition is associated with a rare, de novo Pro814Leu variant in the major human Munc13 paralog UNC13A (also known as Munc13-1). Electrophysiological studies in murine neuronal cultures and functional analyses in Caenorhabditis elegans revealed that the UNC13A variant causes a distinct dominant gain of function that is characterized by increased fusion propensity of synaptic vesicles, which leads to increased initial synaptic vesicle release probability and abnormal short-term synaptic plasticity. Our study underscores the critical importance of fine-tuned presynaptic control in normal brain function. Further, it adds the neuronal Munc13 proteins and the synaptic vesicle priming process that they control to the known etiological mechanisms of psychiatric and neurological synaptopathies.

DOI10.1172/JCI90259
Alternate JournalJ. Clin. Invest.
PubMed ID28192369
PubMed Central IDPMC5330740
Grant ListR01 GM095674 / GM / NIGMS NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States

Person Type: